Cited by 1,924Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyAbdominal Surgery and Complications

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Open access

Russell, James A., Walley, Keith R., Singer, Joel, Gordon, Anthony C., Hébert, Paul C., Cooper, D. James, Holmes, Cheryl L., Mehta, Sangeeta, Granton, John T., Storms, Michelle M., Cook, Deborah J., Presneill, Jeffrey J., Ayers, Dieter·2008·New England Journal of Medicine

DOI 10.1056/nejmoa067373

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa067373

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310

Flagged first, then by citations

Show all 36 references

Research works printed but not linked: 2

Argenziano M, 1997, Circulation, 96, II
Chen JM, 1999, Circulation, 100, II

Sorted by citations

Items 601–700 of 999

Advances in Sepsis Research
Bentzer, P., Russell, J. A., & Walley, K. R. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.05.009 · Cited by 20
Self-citation
Outcomes Associated With Norepinephrine Use Among Cardiac Intensive Care Unit Patients with Severe Shock
Burstein, B. J., Vallabhajosyula, S., Ternus, B. W., Murphree, D. H., Barsness, G. W., KASHANI, K. B., & Jentzer, J. C. (2021) · Shock · doi:10.1097/shk.0000000000001767 · Cited by 20
Outcome of acute kidney injury: how to make a difference?
Jamme, M., Legrand, M. M., & Géri, G. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00849-x · Cited by 23
Machine learning to predict vasopressin responsiveness in patients with septic shock
Scheibner, A. C., Betthauser, K. D., Bewley, A. F., Juang, P., Lizza, B. D., Micek, S. T., & Lyons, P. G. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2683 · Cited by 20
Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock
Brask, A. L., Shemanski, S., Barnes, T. E., & Holmes, A. K. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221118903 · Cited by 20
Complex Pathophysiology of Acute Kidney Injury (AKI) in Aging: Epigenetic Regulation, Matrix Remodeling, and the Healing Effects of H2S
Gupta, S., Mandal, S., Banerjee, K., Almarshood, H., Pushpakumar, S. B., & Sen, U. (2024) · Biomolecules · doi:10.3390/biom14091165 · Cited by 23
Prävention, Diagnose, Therapie und Nachsorge der Sepsis
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. ‐., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-010-0169-2 · Cited by 20
Moderate-dose Vasopressin Therapy May Impair Gastric Mucosal Perfusion in Severe Sepsis
Klinzing, S., Simon, M., Reinhart, K., Meier‐Hellmann, A., & Sakr, Y. L. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318219d74f · Cited by 20
Control groups in recent septic shock trials: a systematic review
Pettilä, V., Hjortrup, P. B., Jakob, S. M., Wilkman, E., Perner, A., & Takala, J. A. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4444-y · Cited by 20
Perioperative Myocardial Infarction in Non-Cardiac Surgery Patients: A Prospective Observational Study
Ollila, A., Vikatmaa, L., Virolainen, J., Vikatmaa, P., Ak, L., Albäck, A., Salmenperä, M., & Pettilä, V. (2016) · Scandinavian Journal of Surgery · doi:10.1177/1457496916673585 · Cited by 20
Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit
Merchan, C., Altshuler, D., & Papadopoulos, J. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016677310 · Cited by 20
The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock
Saad, A. F., & Maybauer, M. O. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.03.008 · Cited by 20
Perioperative renal protection
Canet, E., & Bellomo, R. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000560 · Cited by 21
Pulmonary Hypertension in Intensive Care Units: An Updated Review.
Nowroozpoor, A., Malekmohammad, M., Seyyedi, S. R., & Hashemian, S. M. R. (2019) · PubMed Central · Cited by 20
Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States
Bosch, N. A., Teja, B. J., Wunsch, H., & Walkey, A. J. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-196oc · Cited by 19
Definitions of acute renal dysfunction: an evolving clinical and biomarker paradigm
Ostermann, M., Wu, V., Sokolov, D., & Lumlertgul, N. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000886 · Cited by 20
Inotropes and vasopressors: more than haemodynamics!
Bracht, H., Calzia, E., Georgieff, M., Singer, J., Radermacher, P., & Russell, J. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01776.x · Cited by 20
Self-citation
Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
Asfar, P., & Radermacher, P. (2009) · Critical Care · doi:10.1186/cc7954 · Cited by 20
Pharmacologic agents for acute hemodynamic instability: Recent advances in the management of perioperative shock- A systematic review
Ramakrishna, H., & Morozowich, S. T. (2015) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.166464 · Cited by 20
Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge*
Chagnon, F., Vaidya, V. S., Plante, G. E., Bonventre, J. V., Bernard, A., Guindi, C., & Lesur, O. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318186a938 · Cited by 20
Pilot safety study of low-dose vasopressin in non-septic critically ill children
Baldasso, E., Garcia, P. C. R., Piva, J. P., Branco, R. G., & Tasker, R. C. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1392-1 · Cited by 20
Arginine vasopressin in the treatment of vasodilatory septic shock
Holmes, C. L., & Walley, K. R. (2008) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2008.03.002 · Cited by 21
Self-citation
Biomarker Enrichment in Sepsis-Associated Acute Kidney Injury: Finding High-Risk Patients in the Intensive Care Unit
Baeseman, L. G., Gunning, S., & Koyner, J. L. (2023) · American Journal of Nephrology · doi:10.1159/000534608 · Cited by 22
Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials
Chen, C., Pang, L., Wang, Y., Wen, T., Yu, W., Yue, X., Rong, Y., & Liao, W. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.134 · Cited by 19
EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK
Rydz, A. C., Elefritz, J. L., Conroy, M. E., Disney, K. A., Miller, C. J., Porter, K. M., & Doepker, B. A. (2022) · Shock · doi:10.1097/shk.0000000000001978 · Cited by 19
Characterizing vasopressin and other vasoactive mediators released during resuscitation of trauma patients
Cohn, S. M., DeRosa, M., McCarthy, J., Song, J., White, C. E., Louden, C., Ehler, B. R., Michalek, J. E., & Landry, D. W. (2013) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31829eff31 · Cited by 19
Pilot Study Comparing Sepsis Management with and without Electronic Clinical Practice Guidelines in an Academic Emergency Department
Bond, C. M., Djogovic, D., Villa‐Roel, C., Bullard, M. J., Meurer, D. P., & Rowe, B. H. (2012) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.08.025 · Cited by 19
Approach to the Patient with Sepsis
Martin, J. B., & Wheeler, A. P. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.09.005 · Cited by 19
Acute kidney injury
Glassford, N. J., & Bellomo, R. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834cd334 · Cited by 19
Use of pressor therapy in 34 hypotensive critically ill neonatal foals
DICKEY, E. J., McKenzie, H. C., Johnson, A. K., & Furr, M. O. (2010) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.2010.00652.x · Cited by 19
Impact of Norepinephrine Weight-Based Dosing Compared With Non–Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock
Vadiei, N., Daley, M. J., Murthy, M. S., & Shuman, C. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016682030 · Cited by 19
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock
Bauer, S. R., Sacha, G. L., & Lam, S. W. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2147 · Cited by 18
Efficacy of Transthoracic Echocardiography for Diagnosing Heart Failure in Septic Shock
Beraud, A.-S., Guillamet, C. V., Hammes, J. L., Meng, L., Nicolls, M. R., & Hsu, J. L. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318297d616 · Cited by 19
Advances in resuscitation strategies
Alam, H. B. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.09.001 · Cited by 19
Experimental sepsis in pigs—effects of vasopressin on renal, hepatic, and intestinal dysfunction
Ji, M., Yang, J., Wu, J., Li, R., Li, G.-M., Fan, Y., & Li, W. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2011.650796 · Cited by 19
Hypothalamus and Pituitary
Chambers, D. J., Huang, C. L.-H., & Matthews, G. D. K. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108565011.083 · Cited by 19
When can we start early enteral nutrition safely in patients with shock on vasopressors?
Wang, L., Zhong, X., Yang, H., Yang, J., Zhang, Y., Zou, X., Wang, L., Zhang, Z., Jin, X., Kang, Y., et al. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.03.007 · Cited by 19
Current standard of care for septic shock
Delaney, A. P., Borges-Sa, M., Chew, M. S., Waele, J. J. D., Dye, J., Khanna, A. K., Hamzaoui, O., Hammond, N. E., Glenn Hernández, P., Herridge, M. S., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08211-6 · Cited by 19
A Case Study in Intra-abdominal Sepsis
Paul, J. S., & Ridolfi, T. J. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.08.014 · Cited by 18
Genetic and epigenetic factors in the regulation of the immune response
Dahmer, M. K., Cornell, T. T., & Quasney, M. W. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000356 · Cited by 18
The IL20 Genetic Polymorphism Is Associated with Altered Clinical Outcome in Septic Shock
Nakada, T., Wacharasint, P., Russell, J. A., Boyd, J. H., Nakada, E., Thair, S. A., Shimada, T., & Walley, K. R. (2018) · Journal of Innate Immunity · doi:10.1159/000486104 · Cited by 18
Self-citation
Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
Kaddoura, R., Elmoheen, A. M., Badawy, E., Eltawagny, M., Seif, M. A., Bashir, K., & Salam, A. M. (2021) · Journal of Drug Assessment · doi:10.1080/21556660.2021.1930548 · Cited by 18
Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock
Jakowenko, N. D., Murata, J., Kopp, B. J., & Erstad, B. L. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221081836 · Cited by 18
The Effects of Terlipressin on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis
Ishikawa, K., Wan, L., Calzavacca, P., Bellomo, R., Bailey, M., & May, C. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029693 · Cited by 18
Attitudes to drug trials among relatives of unconscious intensive care patients
Perner, A., Ibsen, M., & Bonde, J. (2010) · BMC Anesthesiology · doi:10.1186/1471-2253-10-6 · Cited by 18
Arginine-vasopressin attenuates beneficial norepinephrine effect on jejunal mucosal tissue oxygenation during endotoxinaemia
Maier, S., Hasibeder, W., Pajk, W., Hengl, C., Ulmer, H., Hausdorfer, H., Wurzinger, B., & Knotzer, H. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep239 · Cited by 18
Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital
Russell, J. A., Wellman, H., & Walley, K. R. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0344-2 · Cited by 18
Self-citation
Less is more: catecholamine-sparing strategies in septic shock
Venkatesh, B., Khanna, A. K., & Cohen, J. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05770-3 · Cited by 18
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis
Reitz, K. M., Kennedy, J., Rieser, C. J., Hlavin, C., Gershengorn, H. B., Neal, M. D., Bensen, N., Linstrum, K., Prescott, H. C., Rosengart, M. R., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202105-547oc · Cited by 18
Intraoperative administration of vasopressin during coronary artery bypass surgery is associated with acute postoperative kidney injury
Porhomayon, J., Davari-Farid, S., Li, C. M., Arora, P., Pourafkari, L., & Nader, N. D. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.06.013 · Cited by 18
Impact of Early Postoperative Hydrocortisone Administration in Cardiac Surgical Patients after Cardiopulmonary Bypass
Ensor, C. R., Sabo, R., & Voils, S. A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p468 · Cited by 18
Steroid Therapy of Septic Shock
Sprung, C. L., Goodman, S. V., & Weiss, Y. (2011) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2010.12.010 · Cited by 18
A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock
Wong, A., Alkazemi, A., Eche, I. M., Petri, C. R., Sarge, T., & Cocchi, M. N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619872720 · Cited by 18
Protective hemodynamics: a novel strategy to manage blood pressure
D’Amico, F., & Landoni, G. (2024) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001205 · Cited by 18
Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review
Ortoleva, J. P., Dalia, A. A., Convissar, D. L., Pisano, D. V., Bittner, E. A., & Berra, L. M. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.01.012 · Cited by 18
Vasopressin in Pediatric Critical Care
Choong, K. L. M. (2016) · Journal of Pediatric Intensive Care · doi:10.1055/s-0036-1583282 · Cited by 20
Vasopressors During Sepsis
Gelinas, J. P., & Russell, J. A. (2016) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2016.01.008 · Cited by 17
Self-citation
Practical Considerations in Sepsis Resuscitation
Long, B., Koyfman, A., Modisett, K. L., & Woods, C. J. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.10.008 · Cited by 17
Methylene Blue for Refractory Shock in Children: A Systematic Review and Survey Practice Analysis
Luna, A. O., Johnson, R., Funaro, M. C., Canarie, M. F., & Pierce, R. W. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002295 · Cited by 22
Safety of treating acute liver injury and failure
García‐Cortés, M., Ortega‐Alonso, A., & Andrade, R. J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1955854 · Cited by 17
Ventriculo-arterial (un)coupling in septic shock: Impact of current and upcoming hemodynamic drugs
Demailly, Z., Besnier, E., Tamion, F., & Lesur, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1172703 · Cited by 17
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: Review of the literature
Meyer, S., McGuire, W. L., Gottschling, S., Shamdeen, G. M., & Gortner, L. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0853-7 · Cited by 17
Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial
Okamoto, Y., Nohmi, T., Higa, Y., Seki, K., & Yamashita, A. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.07.007 · Cited by 17
Pressor response to fluid resuscitation in endotoxic shock: Involvement of vasopressin*
Batista, M. B., Bravin, A. C., Lopes, L. M., Gerenuti, E., Elias, L. L. K., Antunes‐Rodrigues, J., & Giusti‐Paiva, A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b02e3b · Cited by 17
Genomics and pharmacogenomics of sepsis: so close and yet so far
Russell, J. A. (2016) · Critical Care · doi:10.1186/s13054-016-1374-6 · Cited by 17
Self-citation
Vasodilatory shock in the ICU and the role of angiotensin II
Wakefield, B. J., Sacha, G. L., & Khanna, A. K. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000517 · Cited by 20
Are large randomised controlled trials in severe sepsis and septic shock statistically disadvantaged by repeated inadvertent underestimates of required sample size?
Wong, J. L. C., Mason, A. J., Gordon, A. C., & Brett, S. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020068 · Cited by 17
Self-citation
Dobutamine Versus Vasopressin After Mesenteric Ischemia
Bomberg, H., Bierbach, B., Flache, S., Novák, M., Schäfers, H., & Menger, M. D. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.10.028 · Cited by 16
Angiotensin II in Vasodilatory Shock
Wakefield, B. J., Busse, L. W., & Khanna, A. K. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.003 · Cited by 17
Hydrocortisone in Vasodilatory Shock
Venkatesh, B., & Cohen, J. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.005 · Cited by 17
Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock
Coleman, P. J., Nissen, A. P., Kim, D. E., Ainsworth, C., McCurdy, M. T., Mazzeffi, M. A., & Chow, J. H. (2019) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253219877876 · Cited by 18
Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock
Yerke, J. R., Sacha, G. L., Scheraga, R. G., Culver, D. A., Abraham, S., Torbic, H., Lam, S. W., Ammar, M. A., Olman, M. A., & Bauer, S. R. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2346 · Cited by 17
Intravenous Arginine Vasopressin Infusion in Refractory Vasodilatory Shock: A Clinical Study
Agrawal, A., Singh, V., Varma, A., & Sharma, R. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0557-z · Cited by 17
Current Concepts in Resuscitation
Pieracci, F. M., Biffl, W. L., & Moore, E. E. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066610394318 · Cited by 17
Pharmacological treatment of sepsis
Girbes, A. R. J., Beishuizen, A., & van Schijndel, R. J. M. S. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00606.x · Cited by 17
Sepsis
Karnatovskaia, L. V., & Festić, E. (2012) · The Neurohospitalist · doi:10.1177/1941874412453338 · Cited by 17
Haemodynamic management of septic shock
Kotani, Y., Ryan, N., Udy, A. A., & Fujii, T. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae081 · Cited by 18
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock
Leisman, D. E., Wieruszewski, P. M., Busse, L. W., Chawla, L. S., Hibbert, K. A., Handisides, D. R., Khanna, A. K., Ostermann, M., McCurdy, M. T., Adams, C., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05311-z · Cited by 16
Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)
Léone, M., Myatra, S. N., Dugar, S. P., Wieruszewski, P. M., Russell, L., Evans, L., Delamarre, L., Sharif, S., Chew, M. S., Gong, M. N., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007124 · Cited by 17
Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline
Nascente, A. P. M., Freitas, F. G. R., Bakker, J., Bafi, A. T., Ladeira, R. T., Azevedo, L. C. P., Lima, A. A. P., & Machado, F. R. (2017) · Clinics · doi:10.6061/clinics/2017(12)06 · Cited by 16
Controversies in Sepsis Management—What is the Way Forward?
Lo, A. H., Kee, A. C. L., Li, A., & Rubulotta, F. M. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.202090 · Cited by 16
Norepinephrine May Exacerbate Septic Acute Kidney Injury: A Narrative Review
Al-Husinat, L., Alsabbah, A., Hmaid, A. A., Athamneh, R., Adwan, M., Hourani, M. N., Almakhadmeh, S., Modanat, Z. J. A., Ismail, M. I. A., & Varrassi, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041373 · Cited by 16
Early management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 16
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 20
Guidelines on Management of Human Infection with the Novel Virus Influenza A (H1N1) – A Report from the Hospital das Clínicas of the University of São Paulo
Hajjar, L. A., Schout, D., Galas, F. R. B. G., Uip, D. É., Levin, A. S., Caiaffa-Filho, H., Sakane, P. T., Suslik, C. A., Teixeira, J. M. D. C., Bonfá, E., et al. (2009) · Clinics · doi:10.1590/s1807-59322009001000013 · Cited by 15
Shock – an overview
McLuckie, A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-3096-3.00011-7 · Cited by 16
Septic shock resuscitation in the first hour
Simpson, N., Lamontagne, F., & Shankar‐Hari, M. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000460 · Cited by 16
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis
Busse, L. W., Nicholson, G., Nordyke, R. J., Lee, C.-H., Zeng, F., & Albertson, T. E. (2020) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462320000082 · Cited by 17
Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
Yao, R.-Q., Xia, D., Wang, L., Wu, G., Zhu, Y., Zhao, H., Liu, Q., Xia, Z., Ren, C., & Yao, Y.-M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00563 · Cited by 17
Blood Interleukin-6 Levels Predict Multiple Organ Dysfunction in Critically Ill Patients
Shimazui, T., Nakada, T., Yazaki, M., Mayumi, T., Takasu, O., Matsuda, K., Sasaki, J., Otsubo, H., Teshima, Y., Nabeta, M., et al. (2020) · Shock · doi:10.1097/shk.0000000000001678 · Cited by 16
Effectiveness of Angiotensin II for Catecholamine Refractory Septic or Distributive Shock on Mortality: A Propensity Score Weighted Analysis of Real-World Experience in the Medical ICU
Quan, M., Cho, N., Bushell, T., Mak, J., Nguyen, N., Litwak, J., Rockwood, N., & Nguyen, H. B. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000623 · Cited by 16
Sepsis: The Inflammatory Foundation of Pathophysiology and Therapy
Li, J., Carr, B. G., Goyal, M. K., & Gaieski, D. F. (2011) · Hospital Practice · doi:10.3810/hp.2011.08.585 · Cited by 16
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*
Rehberg, S. W., Enkhbaatar, P., Rehberg, J., La, E., Ferdyan, N., Qi, S., Wiśniewski, K., Traber, L. D., Schteingart, C. D., Rivière, P. J.-M., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31824e0fe5 · Cited by 16
Current management of sepsis in critically ill adult patients
Vincent, J., Serrano, E. C., & Dimoula, A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.65 · Cited by 16
Adrenergic Support in Septic Shock: A Critical Review
Póvoa, P. M. S. R., & Carneiro, A. (2010) · Hospital Practice · doi:10.3810/hp.2010.02.280 · Cited by 16
Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats
Leite-Avalca, M. C. G., Lomba, L. A., Bastos-Pereira, A. L., Brito, H. O., Fraga, D., & Zampronio, A. R. (2016) · Shock · doi:10.1097/shk.0000000000000598 · Cited by 17
Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study
study, T. E. T. C. A. S. I. S. S.-R.-I. (.-R., Brown, S. M., Beesley, S. J., Lanspa, M. J., Grissom, C. K., Wilson, E. L., Parikh, S. M., Sarge, T., Talmor, D. S., Banner‐Goodspeed, V., et al. (2018) · Pilot and Feasibility Studies · doi:10.1186/s40814-018-0321-5 · Cited by 17
Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies
Hammond, D. A., Rech, M. A., Daley, M. J., Devlin, J. W., Hodge, E. K., Kooda, K. J., Lat, I., Personett, H. A., Roberts, R. J., Sacha, G. L., et al. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1079 · Cited by 15
Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies
Heavner, M. S., McCurdy, M. T., Mazzeffi, M. A., Galvagno, S. M., Tanaka, K. A., & Chow, J. H. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620911601 · Cited by 16
Vasoplegia Syndrome After Cardiac Surgery
Castagna, F., Mehra, M. R., Nabzdyk, C. S., & Givertz, M. M. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.02.028 · Cited by 18

Authors: Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
Affiliations: St. Paul's Hospital (CA)
University of Ottawa (CA)
The Alfred Hospital (AU)
University of British Columbia (CA)
Mount Sinai Hospital (CA)
University of Toronto (CA)
McMaster University (CA)
The Royal Melbourne Hospital (AU)
ORCID: Russell, James A.
Walley, Keith R.
Singer, Joel
Gordon, Anthony C.
Hébert, Paul C.
Cooper, D. James
Holmes, Cheryl L.
Mehta, Sangeeta
Granton, John T.
Presneill, Jeffrey J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-02-28
Volume: 358
Issue: 9
Pages: 877-887
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa067373
OpenAlex: W2108153775
Cited by: 1,924
References: 36
Citations by year: 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
FWCI: 88.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
Keywords: septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
MeSH terms: Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks